| Host: |
HEK293 |
| Note: |
STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-Cynomolgus CD3E&CD3D/CD3 epsilon&CD3 delta-C-hFc protein was developed from hek293 and has a target region of C-hFc. For use in research applications. |
| Conjugation: |
Biotin |
| Formulation: |
Lyophilised from 0.2 µm filtered PBS solution pH7.4. |
| Dilution Range: |
Upon receipt centrifuge vial to ensure maximal product extraction, recommended: 20sec, 5K RPM |
| Storage Instruction: |
The lyophilized protein is stable for at least 1 year from date of receipt at-20°C. |
| Endotoxin: |
Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg). |
| Immunogen Region: |
Gln22-Asp117 (CD3E) & Phe22-Ala105 (CD3D) |
| Immunogen: |
DNA sequence encoding Cynomolgus CD3E&CD3D/CD3 epsilon&CD3 delta (Primary Amine Labeling) including a C-hFc tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology. |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
